HPV16感染患者临床特点分析

Abstract
Figure/Table
References
Related Citation (1)

Download: PDF (1215 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To probe the clinical characteristics of patients with high-risk human papillomavirus of human papilloma virus (HPV)16 infection. Methods A total of 542 patients who were positive for HPV in HPV molecular test were selected from Beijing Jingmei Group General Hospital from January 2013 to December 2021. The patients were analyzed for co-infection with other HPV, infection in different age groups and negative conversion of HPV16. Results Of the 542 patients, 330(60.9%) were single positive, 173(31.9%) were complicated with other high-risk infections, and 39(7.2%) were complicated with low-risk infections The prevalence rate of CIN II and above in cervical biopsy with other high risk group (44.2%) was higher than that in cervical biopsy with low risk group (21.4%),(χ²=4.880, P=0.027) . There was no significant difference in the overall distribution of the three types of infection among the age groups ≤29,30-39,40-49,50-59 and ≥60,(χ²=11.185, P=0.191) . There was no significant difference in the constituent ratio of cervical biopsy between ≤29-year-old group and 30-49-year-old group (χ²=3.369, P=0.338) .The detection rate of CIN III in 30-49 age group was higher than that in other age groups (χ²=4.566, P=0.033), and the detection rate of CIN was higher in under 50 age group (χ²=10.313,P<0.001). Among the 183 follow-up patients, 134 cases turned negative for HPV16, with a median time of 16 months (2-75 months), and 152 cases turned negative for HPV16, with a median time of 1-39 months (1-39 months), the median was 8 months(U=6681,P＜0.0001). Conclusions Clinically, colposcopic biopsy should be performed actively for patients with HPV16 infection who are less than 50 years old and complicated with other high-risk infections.

Key words： HPV16 infection coinfection turning negative time colposcopy biopsy

Received: 09 September 2022

ZTFLH:

R446.9

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	WANG Qiuhong
	DU Guiqing
	DENG Guixia
	SHAO Linjuan

Cite this article:

WANG Qiuhong,DU Guiqing,DENG Guixia等. Clinical characteristics of patients with HPV16 infection[J]. Med. J. Chin. Peop. Armed Poli. Forc., 2023, 34(3): 214-216.

URL:

http://journal08.magtechjournal.com/Jwk_wjyx/EN/ OR http://journal08.magtechjournal.com/Jwk_wjyx/EN/Y2023/V34/I3/214

[1]	李想,刘灿,周维,等. 2005-2015年中国宫颈癌发病与死亡趋势分析[J].华中科技大学学报(医学版),2021,50(3):325-330,346.
[2]	中国抗癌协会妇科肿瘤专业委员会. 子宫颈癌诊断与治疗指南(2021年版)[J].中国癌症杂志,2021,31(6):474-489.
[3]	Bertoli H K,Thomsen L T,Iftner T,et al. Risk of vulvar,vaginal and anal high-grade intraepithelial neoplasia and cancer according to cervical humanpapillomaviyus(HPV) status: apopulation based prospective cohort[J].Gynecol Oncol,2020,157(2):456-462.
[4]	田凌君,吴素慧,李雪,等. HPV 与宫颈癌及癌前病变的研究进展[J]. 中国医师杂志,2017,19(9):1437-1440.
[5]	Olusola P,Banerjee H N,Philley J V,et al. Human papilloma virus-associated cervical cancer and health disparities[J]. Cells,2019,8(6):622-633.
[6]	Chan C K,Aimagambetova G,Ukybassova T,et al. Human papillomavirus infection and cervical cancer: epidemiology screening and vaccination - review of current perspectives[J]. J Oncol,2019,2019: 3257939.
[7]	匡婷.HPV感染对宫颈癌转移前微环境的影响[J].医学研究生学报,2021,34(4):434-438.
[8]	李柱娟,李华,陈丽. HPV16感染与宫颈鳞癌的相关性及对PI3K/AKT信号[J]. 热带医学杂志,2021,21(5):618-622.
[9]	Schiffman M,Doorbar J,Wentzensen N, et al.Carcinogenic human papillomavirus infection[J].Nat Rev Dis Primers,2016,12(1);2:16086.
[10]	Perkins R B, Guido R S,Castle P E,et al.2019 ASCCP risk based management consensus guidelines for abnormal cervical cancer screening tests and cancer precirsors[J].J Low Genit Tract Dis,2020,24(2):102-131.
[11]	钟兴明,杜明娣,荆春霞,等.高危型HPV持续感染与宫颈癌前病变的相关性[J].中国热带医学,2018,18(3):267-270.
[12]	吴晓雪.人乳头瘤病毒HPV16整合与宫颈病变程度的观察[J].实用妇科内分泌杂志:电子版,2018,5(27):21-23.
[13]	刘建华,王华.高危型HPV感染导致宫颈癌发生的风险评估[J].医学研究生学报,2017,30(12):1233-1237.
[14]	Fontham E,Wolf A,Church T R,et al.Cervical cancer screeningfor individuals at aver agerisk:2020 guideline update from the American Cancer Society[J].CA Cancer J Clin,2020:Onlineahead of print.
[15]	李云香,陈旭华.3217例妇女高危型HPV感染与年龄的关系[J].实用临床医学,2016,30(1):45-49.
[16]	Szymonowicz K A,Chen J.Biological and clinical aspects of HPV related cancers [J]. Cancer Biol Med,2020,17(4):864-878.
[17]	罗聪聪.宫颈持续高危型HPV感染与机体全身免疫功能相关性的临床研究[D].长春:吉林大学,2021.